- Home
- ICLR vs JEF Comparison
ICLR vs JEF Comparison
Compare ICLR & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- JEF
- Stock Information
- Founded
- ICLR 1990
- JEF 1968
- Country
- ICLR Ireland
- JEF United States
- Employees
- ICLR N/A
- JEF N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- JEF Investment Bankers/Brokers/Service
- Sector
- ICLR Health Care
- JEF Finance
- Exchange
- ICLR Nasdaq
- JEF Nasdaq
- Market Cap
- ICLR 14.3B
- JEF 10.5B
- IPO Year
- ICLR 1998
- JEF N/A
- Fundamental
- Price
- ICLR $158.26
- JEF $55.94
- Analyst Decision
- ICLR Buy
- JEF Buy
- Analyst Count
- ICLR 15
- JEF 4
- Target Price
- ICLR $211.36
- JEF $71.00
- AVG Volume (30 Days)
- ICLR 963.6K
- JEF 2.8M
- Earning Date
- ICLR 10-22-2025
- JEF 09-29-2025
- Dividend Yield
- ICLR N/A
- JEF 2.87%
- EPS Growth
- ICLR N/A
- JEF 25.06
- EPS
- ICLR 7.47
- JEF 2.92
- Revenue
- ICLR $8,102,602,000.00
- JEF $7,231,501,000.00
- Revenue This Year
- ICLR N/A
- JEF $5.64
- Revenue Next Year
- ICLR $0.89
- JEF $10.05
- P/E Ratio
- ICLR $21.29
- JEF $19.13
- Revenue Growth
- ICLR N/A
- JEF 15.68
- 52 Week Low
- ICLR $125.10
- JEF $39.28
- 52 Week High
- ICLR $228.29
- JEF $82.68
- Technical
- Relative Strength Index (RSI)
- ICLR 34.03
- JEF 50.04
- Support Level
- ICLR $155.00
- JEF $52.09
- Resistance Level
- ICLR $167.87
- JEF $54.82
- Average True Range (ATR)
- ICLR 7.71
- JEF 1.70
- MACD
- ICLR -2.47
- JEF 0.45
- Stochastic Oscillator
- ICLR 7.39
- JEF 66.40
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About JEF Jefferies Financial Group Inc.
Jefferies is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since merging, Jefferies became the bedrock of the business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.